In 2017 the FDA has placed a warning on gadolinium contrast agents commonly used for MRI and wants more research on which agents remain in the body and any short and long-term safety information on these things. In the meantime, it would be smart to look at the chart provided by the FDA (see below) to see which ones appear to be safer…
Dr. Mark Moyad & Dr. Stephen Auerbach talk about taking testosterone after prostate cancer treatment.
PCRI Executive Director, Mark Scholz, MD, helps you understand your prostate cancer medical records.
Dr. Mark Moyad & Dr. Stephen Auerbach discuss sexual dysfunction rehab and how supplements can help.
The mainstays of diagnostic investigations for prostate cancer for many decades have been physical examination, blood tests for PSA levels, and biopsy. Imaging investigations, mainly CT, bone scan, specialized MRI techniques, and the recently developed PSMA theranostic imaging, give additional…
Agent Orange was used during the Vietnam War in an herbicidal warfare program known as Operation Ranch Hand. The United States military sprayed Agent Orange in the jungles of Vietnam and the Korean demilitarized zone to remove
PCRI Executive Director, Mark Scholz, MD, dicusses 4 types of prostate cancer treatments.
PCRI Executive Director, Mark Scholz, MD, explains how monitor and stage prostate cancer.
Press Release: Dendreon Initiates Large-Scale Clinical Trial to Investigate PROVENGE (sipuleucel-T) in Men with Early-Stage Prostate Cancer on Active Surveillance
Dendreon Pharmaceuticals LLC announced it will conduct a large-scale, placebo-controlled clinical trial evaluating the effectiveness of PROVENGE® (sipuleucel-T) in reducing disease progression in men with prostate cancer on active surveillance (AS).
The Prostate Cancer Research Institute is delighted to announce Prostate Digest, the new format for what was formerly Prostate Insights Magazine. Prostate Digest still contains articles from the most prestigious doctors in the field, clinical researchers, support group leaders, and PCRI’s staff. However, Prostate Digest comes in a newspaper! As before, we offer all articles online. If you prefer, you can receive articles directly to your email. Enter your email here or call us at 310-743-2116. To learn more about PCRI, our Medical Review Board, and our Board of Directors, click here.